Tuesday, February 06, 2024 7:01:39 PM
There is a strong argument that the purpose of testing is to produce hope, faith, and excitement in order to keep the cash rolling into MF's pocket. This is a cash cow for him and he has all the motivation in the world to milk it as long as he can. You can't tell me this hasn't happened before with penny stock biotechs. In fact it probably happens more often than not with 2 cent biotechs. It's textbook and MF has the perfect motive for doing this....30k per month of shareholder money automatically sent to his bank account. What reason does he have to stop? The longer he strings investors along the more money goes into his pocket...right? It's not rocket science. What has he produced in 4 years? Nothing...absolutely nothing, but how much of your money has he socked away? The writing was on the wall a long time ago and I think most of you see it but just want your money back which is fair, but I question MF's desire to do anything except keep the ball rolling straight to his bank account. That's the only thing he has ever accomplished and it's worked for him. Hence bucillamine 2.0, and he'll keep doing it until the money stops.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
